Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels - PubMed (original) (raw)
. 2010 Nov 15;106(10):1450-5.
doi: 10.1016/j.amjcard.2010.06.076.
Abigail May Khan, Aaron L Baggish, Victor M Castro, Marc J Semigran, Elizabeth L McCabe, George Moukarbel, Jason Reingold, Sofia Durrani, Gregory D Lewis, Christopher Newton-Cheh, Marielle Scherrer-Crosbie, Lee M Kaplan, Thomas J Wang
Affiliations
- PMID: 21059435
- PMCID: PMC3170817
- DOI: 10.1016/j.amjcard.2010.06.076
Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels
Annabel Chen-Tournoux et al. Am J Cardiol. 2010.
Abstract
Natriuretic peptides have multiple beneficial cardiovascular effects. Previous cross-sectional studies have indicated that obese subjects have lower natriuretic peptide concentrations than those of normal weight. It is not known whether this relative natriuretic peptide deficiency is reversible with weight loss. We studied 132 obese subjects undergoing weight loss surgery with serial measurement of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations at preoperative, early (1 to 2 months), and late postoperative (6 months) points. In addition, 20 subjects also underwent echocardiography at baseline and 6 months after surgery. Significant weight loss was observed after surgery (median body mass index 45.1, 41.0, and 32.9 kg/m(2) for the 3 corresponding points, analysis of variance p <0.001). The median NT-proBNP levels increased substantially (31.6, 66.9, and 84.9 pg/ml; p <0.001). The average intrasubject increase in NT-proBNP at the 2 postoperative points was 3.4 and 5.0 times the preoperative level (p <0.001 for both points vs preoperatively). In the multivariate regression models adjusted for clinical characteristics and insulin resistance, the strongest predictor of the change in NT-proBNP level 6 months after weight loss surgery was the change in weight (p = 0.03). Echocardiography showed a mean intrasubject reduction in left ventricular mass index of 18% (p <0.001) and mild improvements in diastolic function, with no change in ejection fraction. In conclusion, we have demonstrated that weight loss is associated with early and sustained increases in NT-proBNP concentrations, despite evidence of preserved systolic and improved diastolic function. These findings suggest a direct, reversible relation between obesity and reduced natriuretic peptide levels.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures
Figure 1
Plasma NT-proBNP levels after weight loss surgery. *p < 0.05 compared with baseline NT-proBNP †p < 0.05 compared to early post-operative NT-proBNP Early post-operative time point = 1–2 months Late post-operative time point = 6 months
Figure 2
Percent weight loss vs. fold increase in NT-proBNP at the late post-operative time point (6 months) compared to baseline.
Similar articles
- Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function.
Martin J, Bergeron S, Pibarot P, Bastien M, Biertho L, Lescelleur O, Bertrand F, Simard S, Poirier P. Martin J, et al. Can J Cardiol. 2013 Aug;29(8):969-75. doi: 10.1016/j.cjca.2012.11.010. Epub 2013 Feb 4. Can J Cardiol. 2013. PMID: 23380297 - Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
Suthahar N, Meijers WC, Ho JE, Gansevoort RT, Voors AA, van der Meer P, Bakker SJL, Heymans S, van Empel V, Schroen B, van der Harst P, van Veldhuisen DJ, de Boer RA. Suthahar N, et al. Eur J Heart Fail. 2018 Aug;20(8):1205-1214. doi: 10.1002/ejhf.1209. Epub 2018 Jun 1. Eur J Heart Fail. 2018. PMID: 29855124 Free PMC article. - Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction.
Vaishnav J, Chasler JE, Lee YJ, Ndumele CE, Hu JR, Schulman SP, Russell SD, Sharma K. Vaishnav J, et al. J Am Heart Assoc. 2020 Aug 4;9(15):e015738. doi: 10.1161/JAHA.119.015738. Epub 2020 Jul 30. J Am Heart Assoc. 2020. PMID: 32750299 Free PMC article. - B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery.
St Peter JV, Hartley GG, Murakami MM, Apple FS. St Peter JV, et al. Clin Chem. 2006 Apr;52(4):680-5. doi: 10.1373/clinchem.2005.062562. Epub 2006 Feb 23. Clin Chem. 2006. PMID: 16497939 - Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Rørth R, et al. Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17. Circ Heart Fail. 2020. PMID: 32065760
Cited by
- Does the relationship between natriuretic hormones and diastolic function differ by race?
Kapuku GK, Davis HC, Thomas P, Januzzi J, Harshfield GA. Kapuku GK, et al. Am J Med Sci. 2012 Aug;344(2):96-9. doi: 10.1097/MAJ.0b013e31823673fd. Am J Med Sci. 2012. PMID: 22314104 Free PMC article. - Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure.
Kozhuharov N, Martin J, Wussler D, Lopez-Ayala P, Belkin M, Strebel I, Flores D, Diebold M, Shrestha S, Nowak A, Gualandro DM, Michou E, Zimmermann T, Rentsch K, von Eckardstein A, Keller DI, Breidthardt T, Mueller C; BASEL V Investigators. Kozhuharov N, et al. Eur J Heart Fail. 2022 Sep;24(9):1545-1554. doi: 10.1002/ejhf.2618. Epub 2022 Aug 8. Eur J Heart Fail. 2022. PMID: 35851710 Free PMC article. - The effects of exercise training associated with low-level laser therapy on biomarkers of adipose tissue transdifferentiation in obese women.
da Silveira Campos RM, Dâmaso AR, Masquio DCL, Duarte FO, Sene-Fiorese M, Aquino AE Jr, Savioli FA, Quintiliano PCL, Kravchychyn ACP, Guimarães LI, Tock L, Oyama LM, Boldarine VT, Bagnato VS, Parizotto NA. da Silveira Campos RM, et al. Lasers Med Sci. 2018 Aug;33(6):1245-1254. doi: 10.1007/s10103-018-2465-1. Epub 2018 Feb 23. Lasers Med Sci. 2018. PMID: 29473115 Clinical Trial. - N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis.
Ducros J, Larifla L, Merault H, Galantine V, Bassien-Capsa V, Foucan L. Ducros J, et al. Int J Nephrol. 2020 Mar 5;2020:9528014. doi: 10.1155/2020/9528014. eCollection 2020. Int J Nephrol. 2020. PMID: 32206350 Free PMC article. Review. - Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.
Bertoni AG, Wagenknecht LE, Kitzman DW, Marcovina SM, Rushing JT, Espeland MA; Brain Natriuretic Peptide Subgroup of the Look AHEAD Research Group. Bertoni AG, et al. Obesity (Silver Spring). 2012 Jul;20(7):1511-8. doi: 10.1038/oby.2011.296. Epub 2011 Sep 29. Obesity (Silver Spring). 2012. PMID: 21959345 Free PMC article. Clinical Trial.
References
- Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS. B-type natriuretic peptide and Nterminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J. 2006;152:1071–1076. - PubMed
- Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15:1695–1699. - PubMed
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. - PubMed
- Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84:1053–1060. - PubMed
- Yeo KT, Wu AH, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, Sedor FA, Butch AW. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta. 2003;338:107–115. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL086875-04/HL/NHLBI NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- P30 DK040561-15/DK/NIDDK NIH HHS/United States
- R01 HL086875/HL/NHLBI NIH HHS/United States
- K23/PHS HHS/United States
- R01-HL-086875/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials